Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shingrix in autologous HCT recipients
NCT01610414Phase 3Completed
- Sponsor
- GSK
- Start
- Jul 2012
- Primary completion
- Nov 2016
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 28
01
Overview
A Phase 3 trial of herpes zoster vaccine (recombinant, adjuvanted) in herpes zoster (HZ), sponsored by GSK. Started Jul 2012; status: completed.
02
Drugs
herpes zoster vaccine (recombinant, adjuvanted)
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT01610414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01610414.